Acadian Asset Management
SMMT icon

Acadian Asset Management’s Summit Therapeutics SMMT Stock Holding History

Acadian Asset Management’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,722
Closed -$234K – 2122
2024
Q3 		$234K Buy
+10,722
New +$150K ﹤0.01% 1308
2020
Q3 		– Sell
-49,257
Closed -$146K – 2341
2020
Q2 		$146K Sell
49,257
-41,016
-45% -$141K ﹤0.01% 1603
2020
Q1 		$214K Sell
90,273
-40,039
-31% -$68.8K ﹤0.01% 1183
2019
Q4 		$208K Sell
130,312
-43,073
-25% -$69.3K ﹤0.01% 1286
2019
Q3 		$310K Hold
173,385
– – ﹤0.01% 1209
2019
Q2 		$220K Sell
173,385
-2,115
-1% -$3.54K ﹤0.01% 1201
2019
Q1 		$321K Sell
175,500
-7,660
-4% -$12.6K ﹤0.01% 1231
2018
Q4 		$210K Buy
183,160
+10,208
+6% +$15.9K ﹤0.01% 1103
2018
Q3 		$384K Buy
172,952
+66,447
+62% +$153K ﹤0.01% 940
2018
Q2 		$261K Sell
106,505
-30,417
-22% -$389K ﹤0.01% 1018
2018
Q1 		$1.77M Sell
136,922
-7,161
-5% -$89.5K 0.01% 612
2017
Q4 		$1.59M Buy
144,083
+94,876
+193% +$1.06M 0.01% 596
2017
Q3 		$618K Buy
49,207
+36,356
+283% +$471K ﹤0.01% 755
2017
Q2 		$145K Buy
12,851
+1
+0% +$11 ﹤0.01% 989
2017
Q1 		$171K Buy
+12,850
New +$149K ﹤0.01% 1066

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Acadian Asset Management's SMMT Position: Q4 2024 in Review

Acadian Asset Management sold out of Summit Therapeutics (SMMT) in Q4 2024, closing a stake of 10,722 shares — an estimated $234K sold.

Acadian Asset Management first reported a position in SMMT in Q1 2017 and held it in 15 quarters. The position peaked at $1.77M in Q1 2018. 203 funds tracked by Wall St. Rank hold SMMT as of Q4 2024.

  • Acadian Asset Management reported no remaining Summit Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 10,722 Summit Therapeutics shares in Q4 2024, an estimated $234K.
  • Acadian Asset Management first reported a position in Summit Therapeutics in Q1 2017 and held it in 15 quarters.
  • Acadian Asset Management's Summit Therapeutics position peaked at $1.77M in Q1 2018.
  • 203 funds tracked by Wall St. Rank held Summit Therapeutics as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.